• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    4/19/22 11:38:17 AM ET
    $OIA
    $OMER
    $OMGA
    $ONCR
    Finance Companies
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $OIA alert in real time by email

     

    On Tuesday, 242 companies hit new 52-week lows.

    Noteworthy Mentions In Today's 52-Week Lows:

    • The largest company in terms of market cap to set a new 52-week low was Sony Group (NYSE:SONY).
    • Nova Lifestyle (NASDAQ:NVFY) was the smallest firm by market cap to set a new 52-week low.
    • Cassava Sciences (NASDAQ:SAVA) saw the most significant move of the companies, as shares traded down 13.18% to reach its new 52-week low.
    • Starry Group Holdings (NYSE:STRY) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    The stocks that set new 52-week lows on Tuesday:

    • Sony Group (NYSE:SONY) shares made a new 52-week low of $87.54 on Tuesday. The stock was up 0.27% for the day.
    • Truist Financial (NYSE:TFC) shares set a new yearly low of $50.29 this morning. The stock was down 0.85% on the session.
    • Sumitomo Mitsui Financial (NYSE:SMFG) stock broke to a new 52-week low of $6.06 on Tuesday. Shares of the company traded down 0.25%.
    • Wipro (NYSE:WIT) stock hit $6.74 on Tuesday morning, setting a new 52-week low for a change of down 0.36%.
    • United Microelectronics (NYSE:UMC) stock drifted up 0.81% on Tuesday morning to hit a new 52-week low of $7.88.
    • Dentsply Sirona (NASDAQ:XRAY) stock achieved a new 52-week low on Tuesday morning, hitting $41.16 and moving down 12.91%.
    • Repligen (NASDAQ:RGEN) shares were up 1.13% for the day, having made a 52-week low of $149.66.
    • AGNC Investment (NASDAQ:AGNC) shares moved down 2.24% on Tuesday to hit a new 52-week low of $11.94, drifting down 2.24%.
    • Integra Lifesciences (NASDAQ:IART) stock hit $61.27 on Tuesday morning, setting a new 52-week low for a change of up 3.21%.
    • Intellia Therapeutics (NASDAQ:NTLA) stock dropped to a yearly low on Tuesday of $55.50. Shares traded up 1.4%.
    • Novavax (NASDAQ:NVAX) stock hit $50.24 on Tuesday morning, setting a new 52-week low for a change of down 0.38%.
    • Denali Therapeutics (NASDAQ:DNLI) shares made a new 52-week low of $28.11 on Tuesday. The stock was up 1.91% for the day.
    • Viavi Solutions (NASDAQ:VIAV) stock set a new 52-week low of $14.59 on Tuesday, moving up 1.63%.
    • Nuveen Quality Municipal (NYSE:NAD) stock dropped to a yearly low on Tuesday of $12.59. Shares traded down 0.24%.
    • Sabra Health Care REIT (NASDAQ:SBRA) stock set a new 52-week low of $12.23 on Tuesday, moving down 0.65%.
    • Herbalife Nutrition (NYSE:HLF) shares moved up 0.5% on Tuesday to hit a new 52-week low of $27.82, drifting up 0.5%.
    • Oatly Group (NASDAQ:OTLY) shares fell to $4.05 on Tuesday, setting a new 52-week low with a shift of up 3.4%.
    • Chimera Investment (NYSE:CIM) stock achieved a new 52-week low on Tuesday morning, hitting $10.49 and moving down 2.59%.
    • Gogoro (NASDAQ:GGR) stock set a new 52-week low of $7.90 on Tuesday, moving up 12.24%.
    • ImmunityBio (NASDAQ:IBRX) shares hit a yearly low of $4.70. The stock was up 1.7% on the session.
    • Nuveen Municipal Value (NYSE:NUV) stock broke to a new 52-week low of $9.12 on Tuesday. Shares of the company traded down 0.22%.
    • Himax Technologies (NASDAQ:HIMX) stock drifted up 1.54% on Tuesday morning to hit a new 52-week low of $8.85.
    • Invitae (NYSE:NVTA) shares were up 5.49% for the day, having made a 52-week low of $6.01.
    • Canoo (NASDAQ:GOEV) shares set a new yearly low of $4.72 this morning. The stock was up 2.26% on the session.
    • Vivint Smart Home (NYSE:VVNT) shares were up 6.31% for the day, having made a 52-week low of $5.14.
    • LumiraDx (NASDAQ:LMDX) stock broke to a new 52-week low of $4.01 on Tuesday. Shares of the company traded up 5.75%.
    • BlackRock Taxable (NYSE:BBN) stock hit a new 52-week low of $19.16. The stock was up 0.21% on the session.
    • Zentalis Pharmaceuticals (NASDAQ:ZNTL) stock set a new 52-week low of $24.01 on Tuesday, moving up 2.12%.
    • Redwood Trust (NYSE:RWT) shares hit a yearly low of $9.40. The stock was down 1.61% on the session.
    • Blackrock Credit (NYSE:BTZ) shares fell to $11.77 on Tuesday, setting a new 52-week low with a shift of up 0.67%.
    • Starry Group Holdings (NYSE:STRY) shares made a new 52-week low of $6.25 on Tuesday. The stock was 0.0% (flat) for the day.
    • NanoString Technologies (NASDAQ:NSTG) stock set a new 52-week low of $20.64 on Tuesday, moving up 1.54%.
    • Verve Therapeutics (NASDAQ:VERV) stock set a new 52-week low of $17.98 on Tuesday, moving down 0.42%.
    • Alliancebernstein Glb (NYSE:AWF) stock hit a new 52-week low of $10.28. The stock was up 0.58% on the session.
    • Cassava Sciences (NASDAQ:SAVA) shares made a new 52-week low of $18.65 on Tuesday. The stock was down 13.18% for the day.
    • Rocket Pharmaceuticals (NASDAQ:RCKT) stock hit $12.99 on Tuesday morning, setting a new 52-week low for a change of up 2.21%.
    • Coherus BioSciences (NASDAQ:CHRS) stock hit a yearly low of $10.31. The stock was up 1.26% for the day.
    • Eaton Vance Municipal (AMEX:EIM) shares set a new 52-week low of $10.89. The stock traded down 0.09%.
    • Sangamo Therapeutics (NASDAQ:SGMO) shares set a new yearly low of $4.97 this morning. The stock was up 3.05% on the session.
    • BioLife Solns (NASDAQ:BLFS) stock broke to a new 52-week low of $16.08 on Tuesday. Shares of the company traded up 4.22%.
    • Invesco Municipal (NYSE:VMO) shares set a new yearly low of $10.45 this morning. The stock was down 0.47% on the session.
    • MagnaChip Semiconductor (NYSE:MX) shares set a new 52-week low of $14.68. The stock traded up 2.84%.
    • Netgear (NASDAQ:NTGR) stock dropped to a yearly low on Tuesday of $20.55. Shares traded down 4.11%.
    • Sorrento Therapeutics (NASDAQ:SRNE) shares reached a new 52-week low of $1.76 on Tuesday morning, moving up 4.8%.
    • Excelerate Energy (NYSE:EE) stock set a new 52-week low of $25.89 on Tuesday, moving down 4.13%.
    • Castle Biosciences (NASDAQ:CSTL) stock hit $23.25 on Tuesday morning, setting a new 52-week low for a change of up 0.86%.
    • Invesco Mortgage Capital (NYSE:IVR) stock drifted 0.0% (flat) on Tuesday morning to hit a new 52-week low of $1.82.
    • Invesco Value Municipal (NYSE:IIM) stock drifted down 0.53% on Tuesday morning to hit a new 52-week low of $13.07.
    • Nurix Therapeutics (NASDAQ:NRIX) shares reached a new 52-week low of $12.20 on Tuesday morning, moving up 3.15%.
    • Mitek Systems (NASDAQ:MITK) shares made a new 52-week low of $12.87 on Tuesday. The stock was down 0.23% for the day.
    • Invesco Municipal (NYSE:VKQ) shares set a new yearly low of $10.48 this morning. The stock was down 1.22% on the session.
    • Nuvalent (NASDAQ:NUVL) stock set a new 52-week low of $10.82 on Tuesday, moving up 6.53%.
    • Hydrofarm Holdings Group (NASDAQ:HYFM) shares were up 6.26% for the day, having made a 52-week low of $11.71.
    • Blackrock Municipal IT (NYSE:BLE) stock hit a new 52-week low of $11.48. The stock was down 0.29% on the session.
    • Invesco Quality Municipal (NYSE:IQI) stock achieved a new 52-week low on Tuesday morning, hitting $10.45 and moving down 1.48%.
    • Granite Point Mortgage (NYSE:GPMT) stock drifted down 2.33% on Tuesday morning to hit a new 52-week low of $9.98.
    • Berkshire Grey (NASDAQ:BGRY) shares set a new 52-week low of $2.17. The stock traded up 2.26%.
    • Nuveen Taxable Municipal (NYSE:NBB) stock hit a new 52-week low of $18.54. The stock was up 0.16% on the session.
    • Orchid Island Cap (NYSE:ORC) stock broke to a new 52-week low of $2.92 on Tuesday. Shares of the company traded down 1.64%.
    • Nuveen New Jersey Quality (NYSE:NXJ) stock set a new 52-week low of $12.45 on Tuesday, moving down 0.4%.
    • Swvl Hldgs (NASDAQ:SWVL) stock set a new 52-week low of $4.20 on Tuesday, moving down 0.69%.
    • BlackRock MuniHoldings (NYSE:MUC) shares reached a new 52-week low of $11.97 on Tuesday morning, moving down 0.25%.
    • Caribou Biosciences (NASDAQ:CRBU) shares moved up 3.87% on Tuesday to hit a new 52-week low of $7.65, drifting up 3.87%.
    • Blackrock Muni Interm (NYSE:MUI) stock achieved a new 52-week low on Tuesday morning, hitting $12.16 and moving down 0.81%.
    • Cepton (NASDAQ:CPTN) shares reached a new 52-week low of $2.78 on Tuesday morning, moving up 4.94%.
    • Blackrock Muniassets Fund (NYSE:MUA) stock broke to a new 52-week low of $11.63 on Tuesday. Shares of the company traded up 0.68%.
    • Blackrock Muniyield NY (NYSE:MYN) stock achieved a new 52-week low on Tuesday morning, hitting $11.09 and moving down 0.54%.
    • Eaton Vance Municipal IT (NYSE:EVN) shares hit a yearly low of $10.98. The stock was down 0.81% on the session.
    • BNY Mellon Strategic (NYSE:LEO) stock dropped to a yearly low on Tuesday of $6.78. Shares traded down 1.3%.
    • Vaxxinity (NASDAQ:VAXX) shares moved up 0.9% on Tuesday to hit a new 52-week low of $3.20, drifting up 0.9%.
    • Invesco Advantage (AMEX:VKI) shares made a new 52-week low of $9.50 on Tuesday. The stock was down 1.45% for the day.
    • Sight Sciences (NASDAQ:SGHT) stock dropped to a yearly low on Tuesday of $8.62. Shares traded up 0.69%.
    • Akero Therapeutics (NASDAQ:AKRO) shares moved up 2.46% on Tuesday to hit a new 52-week low of $11.04, drifting up 2.46%.
    • Revlon (NYSE:REV) stock drifted up 2.71% on Tuesday morning to hit a new 52-week low of $7.30.
    • Praxis Precision Medicine (NASDAQ:PRAX) shares set a new yearly low of $8.04 this morning. The stock was up 1.08% on the session.
    • Valens Semiconductor (NYSE:VLN) stock achieved a new 52-week low on Tuesday morning, hitting $3.89 and moving down 10.39%.
    • Loyalty Ventures (NASDAQ:LYLT) stock dropped to a yearly low on Tuesday of $14.69. Shares traded up 4.1%.
    • RiverNorth Flex Muni (NYSE:RFMZ) shares hit a yearly low of $15.21. The stock was down 0.52% on the session.
    • Blackrock Muniyield (NYSE:MIY) stock dropped to a yearly low on Tuesday of $12.30. Shares traded down 0.52%.
    • Nuveen New York Quality (NYSE:NAN) stock dropped to a yearly low on Tuesday of $11.61. Shares traded down 0.51%.
    • MFS Intermediate IT (NYSE:MIN) shares set a new yearly low of $3.05 this morning. The stock was down 0.81% on the session.
    • Adagio Therapeutics (NASDAQ:ADGI) shares were up 2.87% for the day, having made a 52-week low of $3.04.
    • Precigen (NASDAQ:PGEN) shares hit a yearly low of $1.62. The stock was up 3.96% on the session.
    • Concrete Pumping Holdings (NASDAQ:BBCP) shares hit a yearly low of $6.07. The stock was down 0.65% on the session.
    • Ooma (NYSE:OOMA) shares set a new yearly low of $14.08 this morning. The stock was down 0.07% on the session.
    • Alliancebernstein Ntnl (NYSE:AFB) shares were down 0.34% for the day, having made a 52-week low of $11.73.
    • Zymeworks (NYSE:ZYME) shares were up 4.77% for the day, having made a 52-week low of $5.20.
    • PIMCO Municipal Income (NYSE:PMX) shares set a new yearly low of $9.46 this morning. The stock was down 1.04% on the session.
    • Personalis (NASDAQ:PSNL) stock hit a new 52-week low of $6.41. The stock was up 4.41% on the session.
    • MFS Charter Income (NYSE:MCR) shares fell to $6.87 on Tuesday, setting a new 52-week low with a shift of down 0.29%.
    • Nuveen Enhanced Municipal (NYSE:NEV) stock set a new 52-week low of $11.99 on Tuesday, moving down 0.58%.
    • Invesco Muni Income Opps (NYSE:OIA) shares were up 0.48% for the day, having made a 52-week low of $6.25.
    • SkyWater Technology (NASDAQ:SKYT) stock hit $7.22 on Tuesday morning, setting a new 52-week low for a change of up 1.56%.
    • G1 Therapeutics (NASDAQ:GTHX) shares moved up 2.82% on Tuesday to hit a new 52-week low of $6.62, drifting up 2.82%.
    • Nuveen California (NYSE:NCA) shares set a new 52-week low of $8.90. The stock traded down 0.31%.
    • Omeros (NASDAQ:OMER) stock broke to a new 52-week low of $4.51 on Tuesday. Shares of the company traded up 0.11%.
    • PIMCO Municipal Income (NYSE:PMF) stock hit a new 52-week low of $11.08. The stock was down 0.09% on the session.
    • Blackrock NY Municipal (NYSE:BNY) shares reached a new 52-week low of $11.46 on Tuesday morning, moving down 0.43%.
    • Marinus Pharma (NASDAQ:MRNS) shares were up 0.14% for the day, having made a 52-week low of $7.11.
    • Allakos (NASDAQ:ALLK) stock achieved a new 52-week low on Tuesday morning, hitting $4.70 and moving up 0.41%.
    • Omega Therapeutics (NASDAQ:OMGA) shares were up 1.87% for the day, having made a 52-week low of $5.09.
    • Invesco Pennsylvania (NYSE:VPV) stock broke to a new 52-week low of $10.76 on Tuesday. Shares of the company traded 0.0% (flat).
    • BlackRock MuniHoldings (NYSE:MUE) shares made a new 52-week low of $11.03 on Tuesday. The stock was down 0.36% for the day.
    • Gritstone Bio (NASDAQ:GRTS) stock hit $3.30 on Tuesday morning, setting a new 52-week low for a change of up 1.03%.
    • Pliant Therapeutics (NASDAQ:PLRX) stock hit $6.59 on Tuesday morning, setting a new 52-week low for a change of down 3.3%.
    • Great Ajax (NYSE:AJX) stock broke to a new 52-week low of $10.12 on Tuesday. Shares of the company traded down 1.98%.
    • MFS Municipal IT (NYSE:MFM) shares were down 0.52% for the day, having made a 52-week low of $5.64.
    • PIMCO CA Muni Income Fund (NYSE:PCK) stock hit a new 52-week low of $7.19. The stock was up 0.69% on the session.
    • MiX Telematics (NYSE:MIXT) stock broke to a new 52-week low of $10.21 on Tuesday. Shares of the company traded up 1.44%.
    • Graphite Bio (NASDAQ:GRPH) shares made a new 52-week low of $3.81 on Tuesday. The stock was up 1.27% for the day.
    • Nuveen Select Tax Free (NYSE:NXP) stock hit $13.86 on Tuesday morning, setting a new 52-week low for a change of down 0.57%.
    • Neuberger Berman (AMEX:NBH) stock hit a new 52-week low of $12.06. The stock was down 0.74% on the session.
    • Greenlight Capital Re (NASDAQ:GLRE) shares set a new yearly low of $6.51 this morning. The stock was up 1.07% on the session.
    • Altimmune (NASDAQ:ALT) stock dropped to a yearly low on Tuesday of $4.92. Shares traded up 1.97%.
    • Pioneer Muni High Inc (NYSE:MAV) stock hit a new 52-week low of $9.09. The stock was down 0.66% on the session.
    • BNY Mellon Municipal Bond (NYSE:DMB) stock hit a new 52-week low of $11.51. The stock was down 0.53% on the session.
    • Viking Therapeutics (NASDAQ:VKTX) shares set a new yearly low of $2.54 this morning. The stock was up 2.14% on the session.
    • American Superconductor (NASDAQ:AMSC) stock hit a yearly low of $6.62. The stock was up 3.28% for the day.
    • Western Asset Invstm Grd (NYSE:IGI) shares were down 0.17% for the day, having made a 52-week low of $17.86.
    • Oil-Dri Corp of America (NYSE:ODC) stock achieved a new 52-week low on Tuesday morning, hitting $26.10 and moving up 0.74%.
    • Japan Smaller (NYSE:JOF) shares set a new yearly low of $6.69 this morning. The stock was down 0.74% on the session.
    • Eaton Vance New York (AMEX:ENX) stock broke to a new 52-week low of $9.79 on Tuesday. Shares of the company traded down 0.91%.
    • Finch Therapeutics Group (NASDAQ:FNCH) stock hit a yearly low of $3.55. The stock was down 4.24% for the day.
    • Kopin (NASDAQ:KOPN) stock hit $1.84 on Tuesday morning, setting a new 52-week low for a change of down 1.59%.
    • Park-Ohio Hldgs (NASDAQ:PKOH) stock set a new 52-week low of $11.86 on Tuesday, moving down 0.33%.
    • ORIC Pharmaceuticals (NASDAQ:ORIC) shares fell to $3.78 on Tuesday, setting a new 52-week low with a shift of down 0.77%.
    • Vapotherm (NYSE:VAPO) stock hit a new 52-week low of $5.53. The stock was up 1.77% on the session.
    • Precision BioSciences (NASDAQ:DTIL) stock achieved a new 52-week low on Tuesday morning, hitting $2.35 and moving up 3.15%.
    • Xilio Therapeutics (NASDAQ:XLO) shares moved down 4.56% on Tuesday to hit a new 52-week low of $5.21, drifting down 4.56%.
    • Shattuck Labs (NASDAQ:STTK) stock achieved a new 52-week low on Tuesday morning, hitting $3.36 and moving up 1.16%.
    • CytomX Therapeutics (NASDAQ:CTMX) stock set a new 52-week low of $2.16 on Tuesday, moving up 1.36%.
    • Western Asset Municipal (NYSE:MHF) shares set a new yearly low of $6.67 this morning. The stock was up 0.01% on the session.
    • BNY Mellon Municipal (AMEX:DMF) shares set a new yearly low of $6.94 this morning. The stock was down 0.71% on the session.
    • Passage Bio (NASDAQ:PASG) shares fell to $2.53 on Tuesday, setting a new 52-week low with a shift of up 0.77%.
    • Zevia (NYSE:ZVIA) stock dropped to a yearly low on Tuesday of $3.65. Shares traded up 0.87%.
    • Blackrock Long-term (NYSE:BTA) stock drifted down 1.59% on Tuesday morning to hit a new 52-week low of $10.49.
    • Enzo Biochem (NYSE:ENZ) shares made a new 52-week low of $2.75 on Tuesday. The stock was up 1.05% for the day.
    • CEL-SCI (AMEX:CVM) stock dropped to a yearly low on Tuesday of $3.13. Shares traded down 12.26%.
    • Federated Hermes Premier (NYSE:FMN) stock hit a yearly low of $11.91. The stock was down 0.43% for the day.
    • Retractable Technologies (AMEX:RVP) shares made a new 52-week low of $3.87 on Tuesday. The stock was down 4.56% for the day.
    • Akouos (NASDAQ:AKUS) shares set a new 52-week low of $3.47. The stock traded up 4.55%.
    • Pixelworks (NASDAQ:PXLW) shares reached a new 52-week low of $2.22 on Tuesday morning, moving up 4.2%.
    • Molecular Templates (NASDAQ:MTEM) stock set a new 52-week low of $2.18 on Tuesday, moving down 0.88%.
    • Checkpoint Therapeutics (NASDAQ:CKPT) stock broke to a new 52-week low of $1.31 on Tuesday. Shares of the company traded down 0.33%.
    • Western Asset Municipal (NYSE:MNP) stock set a new 52-week low of $12.43 on Tuesday, moving down 0.64%.
    • Codex DNA (NASDAQ:DNAY) shares set a new yearly low of $3.94 this morning. The stock was up 0.99% on the session.
    • Athersys (NASDAQ:ATHX) shares made a new 52-week low of $0.47 on Tuesday. The stock was down 3.96% for the day.
    • CytoSorbents (NASDAQ:CTSO) shares reached a new 52-week low of $2.66 on Tuesday morning, moving up 0.74%.
    • Cyteir Therapeutics (NASDAQ:CYT) shares set a new yearly low of $3.09 this morning. The stock was up 4.4% on the session.
    • Western Asset (NYSE:SBI) shares moved down 0.23% on Tuesday to hit a new 52-week low of $8.10, drifting down 0.23%.
    • Curis (NASDAQ:CRIS) stock broke to a new 52-week low of $1.17 on Tuesday. Shares of the company traded up 3.33%.
    • Adverum Biotechnologies (NASDAQ:ADVM) stock hit a new 52-week low of $1.10. The stock was up 1.34% on the session.
    • CVRx (NASDAQ:CVRX) shares set a new yearly low of $4.64 this morning. The stock was up 8.72% on the session.
    • Sientra (NASDAQ:SIEN) shares reached a new 52-week low of $1.72 on Tuesday morning, moving down 3.8%.
    • Magenta Therapeutics (NASDAQ:MGTA) shares made a new 52-week low of $1.85 on Tuesday. The stock was down 3.12% for the day.
    • GoHealth (NASDAQ:GOCO) stock hit $0.85 on Tuesday morning, setting a new 52-week low for a change of up 1.49%.
    • RiverNorth Flexible (NYSE:RFM) stock broke to a new 52-week low of $17.42 on Tuesday. Shares of the company traded down 0.06%.
    • Carrols Restaurant Group (NASDAQ:TAST) shares fell to $1.86 on Tuesday, setting a new 52-week low with a shift of up 1.56%.
    • Mfs High Yield Municipal (NYSE:CMU) stock hit $3.55 on Tuesday morning, setting a new 52-week low for a change of down 2.2%.
    • Harpoon Therapeutics (NASDAQ:HARP) stock achieved a new 52-week low on Tuesday morning, hitting $2.89 and moving down 0.78%.
    • Power REIT (AMEX:PW) shares hit a yearly low of $28.26. The stock was down 0.99% on the session.
    • TCR2 Therapeutics (NASDAQ:TCRR) shares hit a yearly low of $2.26. The stock was up 1.68% on the session.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares set a new 52-week low of $1.75. The stock traded down 1.48%.
    • Western Asset Mortgage (NYSE:WMC) shares made a new 52-week low of $1.50 on Tuesday. The stock was down 0.98% for the day.
    • Akebia Therapeutics (NASDAQ:AKBA) shares hit a yearly low of $0.46. The stock was up 0.91% on the session.
    • icad (NASDAQ:ICAD) shares hit a yearly low of $3.20. The stock was up 1.52% on the session.
    • Bolt Biotherapeutics (NASDAQ:BOLT) stock hit a yearly low of $2.20. The stock was down 1.33% for the day.
    • Brooklyn (NASDAQ:BTX) shares set a new 52-week low of $1.40. The stock traded down 1.03%.
    • Invesco High Income Trust (NYSE:VLT) shares reached a new 52-week low of $11.74 on Tuesday morning, moving up 0.14%.
    • Farmmi (NASDAQ:FAMI) shares were up 1.35% for the day, having made a 52-week low of $0.12.
    • Cardiff Oncology (NASDAQ:CRDF) stock set a new 52-week low of $1.59 on Tuesday, moving down 0.3%.
    • First Trust/aberdeen Glb (NYSE:FAM) shares set a new 52-week low of $6.86. The stock traded 0.0% (flat).
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares made a new 52-week low of $0.46 on Tuesday. The stock was up 0.89% for the day.
    • 180 Degree Capital (NASDAQ:TURN) stock dropped to a yearly low on Tuesday of $6.50. Shares traded up 1.15%.
    • Luby's (NYSE:LUB) shares made a new 52-week low of $2.17 on Tuesday. The stock was down 0.91% for the day.
    • NewAge (NASDAQ:NBEV) stock drifted up 2.94% on Tuesday morning to hit a new 52-week low of $0.44.
    • Avalo Therapeutics (NASDAQ:AVTX) stock set a new 52-week low of $0.57 on Tuesday, moving down 6.73%.
    • Vincerx Pharma (NASDAQ:VINC) shares were up 1.07% for the day, having made a 52-week low of $2.70.
    • Terns Pharma (NASDAQ:TERN) stock hit a yearly low of $2.29. The stock was up 1.53% for the day.
    • NEUBERGER BERMAN NEW YORK (AMEX:NBO) shares moved down 0.38% on Tuesday to hit a new 52-week low of $10.49, drifting down 0.38%.
    • ASLAN Pharma (NASDAQ:ASLN) shares reached a new 52-week low of $0.73 on Tuesday morning, moving up 0.66%.
    • Cryo-Cell International (NASDAQ:CCEL) shares hit a yearly low of $6.25. The stock was down 7.66% on the session.
    • Oncternal Therapeutics (NASDAQ:ONCT) shares reached a new 52-week low of $1.02 on Tuesday morning, moving up 0.95%.
    • Midwest Holding (NASDAQ:MDWT) shares reached a new 52-week low of $13.12 on Tuesday morning, moving down 0.23%.
    • Avrobio (NASDAQ:AVRO) shares made a new 52-week low of $1.06 on Tuesday. The stock was up 4.63% for the day.
    • Elys Game Technology (NASDAQ:ELYS) stock drifted up 1.47% on Tuesday morning to hit a new 52-week low of $1.96.
    • GlycoMimetics (NASDAQ:GLYC) shares set a new yearly low of $0.92 this morning. The stock was up 0.62% on the session.
    • Aravive (NASDAQ:ARAV) shares fell to $1.55 on Tuesday, setting a new 52-week low with a shift of up 3.67%.
    • Eledon Pharma (NASDAQ:ELDN) stock hit a new 52-week low of $2.65. The stock was up 4.86% on the session.
    • Psychemedics (NASDAQ:PMD) stock drifted up 4.91% on Tuesday morning to hit a new 52-week low of $6.24.
    • AcelRx Pharmaceuticals (NASDAQ:ACRX) stock dropped to a yearly low on Tuesday of $0.24. Shares traded down 0.24%.
    • Oncorus (NASDAQ:ONCR) stock set a new 52-week low of $1.34 on Tuesday, moving up 0.36%.
    • First High-School Edu (NYSE:FHS) stock achieved a new 52-week low on Tuesday morning, hitting $1.03 and moving down 7.69%.
    • Biocept (NASDAQ:BIOC) shares were down 1.66% for the day, having made a 52-week low of $1.76.
    • OpGen (NASDAQ:OPGN) shares moved down 6.27% on Tuesday to hit a new 52-week low of $0.60, drifting down 6.27%.
    • Aytu BioPharma (NASDAQ:AYTU) stock drifted down 12.77% on Tuesday morning to hit a new 52-week low of $0.76.
    • Precipio (NASDAQ:PRPO) shares fell to $1.07 on Tuesday, setting a new 52-week low with a shift of down 4.08%.
    • Neovasc (NASDAQ:NVCN) stock achieved a new 52-week low on Tuesday morning, hitting $0.35 and moving down 4.42%.
    • INVO Bioscience (NASDAQ:INVO) shares set a new yearly low of $1.72 this morning. The stock was up 1.14% on the session.
    • Crown ElectroKinetics (NASDAQ:CRKN) stock hit a new 52-week low of $1.26. The stock was down 2.26% on the session.
    • Kubient (NASDAQ:KBNT) shares set a new yearly low of $1.24 this morning. The stock was down 1.57% on the session.
    • Evolving Systems (NASDAQ:EVOL) stock hit $1.26 on Tuesday morning, setting a new 52-week low for a change of down 0.01%.
    • FedNat Holding (NASDAQ:FNHC) shares hit a yearly low of $0.88. The stock was down 6.32% on the session.
    • TOMI Environmental Solns (NASDAQ:TOMZ) stock hit a new 52-week low of $0.75. The stock was down 1.04% on the session.
    • Titan Pharmaceuticals (NASDAQ:TTNP) shares set a new 52-week low of $0.80. The stock traded down 1.44%.
    • Cypress Environmental (NYSE:CELP) shares moved down 6.51% on Tuesday to hit a new 52-week low of $0.70, drifting down 6.51%.
    • Nova Lifestyle (NASDAQ:NVFY) shares made a new 52-week low of $1.13 on Tuesday. The stock was up 3.42% for the day.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $OIA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OIA
    $OMER
    $OMGA
    $ONCR

    CompanyDatePrice TargetRatingAnalyst
    Zevia PBC
    $ZVIA
    2/26/2026$6.00 → $5.00Outperform
    Telsey Advisory Group
    Praxis Precision Medicines Inc.
    $PRAX
    2/24/2026$500.00Outperform
    Wolfe Research
    Denali Therapeutics Inc.
    $DNLI
    2/24/2026Peer Perform
    Wolfe Research
    DENTSPLY SIRONA Inc.
    $XRAY
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    Truist Financial Corporation
    $TFC
    2/17/2026$69.00Equal-Weight → Overweight
    Morgan Stanley
    Mitek Systems Inc.
    $MITK
    2/13/2026$15.00Hold → Buy
    Jefferies
    Passage Bio Inc.
    $PASG
    2/10/2026$21.00Buy
    Chardan Capital Markets
    Park-Ohio Holdings Corp.
    $PKOH
    2/9/2026$37.00Sector Weight → Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $OIA
    $OMER
    $OMGA
    $ONCR
    SEC Filings

    View All

    Nuveen Municipal Value Fund Inc. filed SEC Form 8-K: Other Events

    8-K - NUVEEN MUNICIPAL VALUE FUND INC (0000812801) (Filer)

    2/27/26 7:00:43 AM ET
    $NUV
    Trusts Except Educational Religious and Charitable
    Finance

    SEC Form S-8 filed by Intellia Therapeutics Inc.

    S-8 - Intellia Therapeutics, Inc. (0001652130) (Filer)

    2/26/26 5:31:47 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form S-8 filed by Personalis Inc.

    S-8 - Personalis, Inc. (0001527753) (Filer)

    2/26/26 5:11:47 PM ET
    $PSNL
    Medical Specialities
    Health Care

    $OIA
    $OMER
    $OMGA
    $ONCR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Zevia PBC with a new price target

    Telsey Advisory Group reiterated coverage of Zevia PBC with a rating of Outperform and set a new price target of $5.00 from $6.00 previously

    2/26/26 6:51:04 AM ET
    $ZVIA
    Beverages (Production/Distribution)
    Consumer Staples

    Wolfe Research initiated coverage on Praxis Precision Medicines with a new price target

    Wolfe Research initiated coverage of Praxis Precision Medicines with a rating of Outperform and set a new price target of $500.00

    2/24/26 7:55:37 AM ET
    $PRAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wolfe Research initiated coverage on Denali Therapeutics

    Wolfe Research initiated coverage of Denali Therapeutics with a rating of Peer Perform

    2/24/26 7:52:18 AM ET
    $DNLI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $OIA
    $OMER
    $OMGA
    $ONCR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Scientific Officer Roberts M Scot

    4 - Altimmune, Inc. (0001326190) (Issuer)

    2/27/26 4:10:07 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Financial Officer Weaver Gregory L

    4 - Altimmune, Inc. (0001326190) (Issuer)

    2/27/26 4:05:36 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Technology Officer Kelly Timothy P sold $12,020 worth of shares (6,228 units at $1.93), decreasing direct ownership by 8% to 73,125 units (SEC Form 4)

    4 - Caribou Biosciences, Inc. (0001619856) (Issuer)

    2/27/26 4:01:13 PM ET
    $CRBU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $OIA
    $OMER
    $OMGA
    $ONCR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND, INC. REPORTS THIRD QUARTER EARNINGS

    NEW YORK, Feb. 27, 2026 /PRNewswire/ -- AllianceBernstein Global High Income Fund, Inc. (NYSE:AWF), a registered closed‑end investment company, today announced earnings for the third quarter ended December 31, 2025. Total net assets of the Fund on December 31, 2025 were $985,227,126 as compared with $993,104,684 on September 30, 2025 and $978,431,163 on December 31, 2024. On December 31, 2025, the net asset value per share was $11.43 based on 86,229,677 shares of common stock outstanding.December 31, 2025September 30, 2025December 31, 2024Total Net Assets$985,227,126$993,104,684$978,431,163NAV Per Share$11.43$11.52$11.35Shares Outstanding 86,229,67786,229,67786,229,677For the period October

    2/27/26 4:06:00 PM ET
    $AWF
    Trusts Except Educational Religious and Charitable
    Finance

    ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026

    ImmunityBio, Inc. ((IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across the company's clinical trial pipeline, and to review financial results for the year ended December 31, 2025. Conference Call Details The conference call will begin at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3, 2026. Interested parties may access the conference call through our Investor Relations website, ir.immunitybio.com, under Company — Events & Presentations. Alternatively, individuals can access the call by dialing 1-844-539-3703 or 1-412-652-1273 (internationally).

    2/27/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Novavax to Participate in Upcoming Investor Conferences

    GAITHERSBURG, Md., Feb. 26, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX), today announced that it will participate in the following upcoming investor conferences:TD Cowen 46th Annual Health Care Conference:Fireside ChatDate:Tuesday, March 3, 2026Time:2:30 p.m. Eastern Time (ET)Location:Boston, MALeerink Partners 2026 Global Healthcare Conference:Fireside ChatDate:Tuesday, March 10, 2026Time:3:40 p.m. ETLocation:Miami Beach, FLJefferies Biotech on the Beach Summit:Investor MeetingsDate:Wednesday, March 11, 2026Location:Miami Beach, FLA webcast of the fireside chats will be available through the Events and Presentations page of the Company's website at ir.novavax.com. A replay of each webc

    2/26/26 4:30:00 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $OIA
    $OMER
    $OMGA
    $ONCR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $OIA
    $OMER
    $OMGA
    $ONCR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jain Mudit K. bought $297,592 worth of shares (46,800 units at $6.36) (SEC Form 4)

    4 - CVRx, Inc. (0001235912) (Issuer)

    2/23/26 6:00:12 AM ET
    $CVRX
    Medical/Dental Instruments
    Health Care

    Director Jain Mudit K. bought $2,785 worth of shares (600 units at $4.64), increasing direct ownership by 12% to 5,650 units (SEC Form 4)

    4 - CVRx, Inc. (0001235912) (Issuer)

    2/18/26 5:22:25 PM ET
    $CVRX
    Medical/Dental Instruments
    Health Care

    Large owner Posner Henry Iii bought $162,929 worth of 7.75% Series A Cum. Red. Perpetual Preferred Stock (24,633 units at $6.61), increasing direct ownership by 263% to 34,000 units (SEC Form 4)

    4 - Power REIT (0001532619) (Issuer)

    2/10/26 2:53:54 PM ET
    $PW
    Real Estate Investment Trusts
    Real Estate

    $OIA
    $OMER
    $OMGA
    $ONCR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Pharmaceuticals Inc.

    SC 13D/A - ROCKET PHARMACEUTICALS, INC. (0001281895) (Subject)

    12/16/24 7:51:51 PM ET
    $RCKT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Federated Hermes Premier Municipal Income Fund

    SC 13D/A - Federated Hermes Premier Municipal Income Fund (0001199004) (Subject)

    12/13/24 5:01:17 PM ET
    $FMN
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by Neuberger Berman Municipal Fund Inc.

    SC 13D/A - NEUBERGER BERMAN MUNICIPAL FUND INC. (0001178839) (Subject)

    12/13/24 4:42:44 PM ET
    $NBH
    Finance/Investors Services
    Finance

    $OIA
    $OMER
    $OMGA
    $ONCR
    Financials

    Live finance-specific insights

    View All

    ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026

    ImmunityBio, Inc. ((IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across the company's clinical trial pipeline, and to review financial results for the year ended December 31, 2025. Conference Call Details The conference call will begin at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3, 2026. Interested parties may access the conference call through our Investor Relations website, ir.immunitybio.com, under Company — Events & Presentations. Alternatively, individuals can access the call by dialing 1-844-539-3703 or 1-412-652-1273 (internationally).

    2/27/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BNY Mellon Municipal Bond Closed-End Funds Declare Distributions

    BNY Mellon Investment Adviser, Inc. announced today that BNY Mellon Strategic Municipal Bond Fund, Inc. and BNY Mellon Strategic Municipals, Inc. (each, a "Fund") have declared a monthly distribution for each Fund's common shares as summarized below. The distributions are payable March 31, 2026 to shareholders of record on March 12, 2026, with an ex-dividend date of March 12, 2026.     Fund     Ticker Monthly Distribution Per Share Change from Prior Monthly Distribution Per Share   BNY Mellon Strategic Municipal Bond Fund, Inc.   DSM $0.026 --   BNY Mellon Strategic Municipals, Inc.   L

    2/26/26 4:13:00 PM ET
    $BK
    $DSM
    $LEO
    Major Banks
    Finance
    Investment Managers
    Trusts Except Educational Religious and Charitable

    Castle Biosciences Reports Fourth Quarter and Full–Year 2025 Results

    2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million Conference call and webcast today at 4:30 p.m. ET FRIENDSWOOD, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the fourth quarter and year ended Dec. 31, 2025."We closed out an outstanding year with a strong fourth quarter, reflecting the strength of our innovative test portfolio, disciplined execution and the dedication of the entire Castle team who continue to d

    2/26/26 4:05:00 PM ET
    $CSTL
    Medical Specialities
    Health Care

    $OIA
    $OMER
    $OMGA
    $ONCR
    Leadership Updates

    Live Leadership Updates

    View All

    Truist Securities appoints Matthew Miller as head of mergers & acquisitions

    Industry veteran brings 30 plus years of experience to full-service investment bankATLANTA, Feb. 26, 2026 /PRNewswire/ -- Truist Securities today announced that Matthew Miller has joined the firm as managing director and head of mergers & acquisitions, strengthening its leadership team and advisory capabilities. In this role, Miller will lead the firm's M&A platform, drive growth initiatives, oversee deal origination and execution, and collaborate with product teams to deliver comprehensive capabilities to public, sponsor-owned, and privately held companies across a range of ind

    2/26/26 8:35:00 AM ET
    $TFC
    Major Banks
    Finance

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Integra LifeSciences Announces Key Executive Leadership Appointments

    PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead research and development (R&D), including product and technology development, across the company. The company also announced the appointments of Michael Hutchinson as executive vice president, chief legal officer and secretary, and Kerri DiPietro as corporate vice president and chief quality officer. The creation of the chief technology officer (CTO) position underscores Integra's commitment to build

    2/17/26 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $OIA
    $OMER
    $OMGA
    $ONCR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care